Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis.

Zhang T, Pope JE.

Rheumatology (Oxford). 2017 Mar 30. doi: 10.1093/rheumatology/kex065. [Epub ahead of print]

PMID:
28379501
2.

A literature review to evaluate the clinical and economic value of olmesartan for the treatment of hypertensive patients.

Kourlaba G, Gialama F, Tsioufis K, Maniadakis N.

Int J Cardiol. 2016 Oct 15;221:60-74. doi: 10.1016/j.ijcard.2016.06.115. Epub 2016 Jun 24. Review.

PMID:
27404671
3.

The effect of losartan on progressive aortic dilatation in patients with Marfan's syndrome: a meta-analysis of prospective randomized clinical trials.

Gao L, Chen L, Fan L, Gao D, Liang Z, Wang R, Lu W.

Int J Cardiol. 2016 Aug 15;217:190-4. doi: 10.1016/j.ijcard.2016.04.186. Epub 2016 May 4.

PMID:
27187761
4.

Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity.

Brewster LM, van Montfrans GA, Oehlers GP, Seedat YK.

Intern Emerg Med. 2016 Apr;11(3):355-74. doi: 10.1007/s11739-016-1422-x. Epub 2016 Mar 30. Review.

5.

Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension.

Akioyamen L, Levine M, Sherifali D, O'Reilly D, Frankfurter C, Pullenayegum E, Goeree R, Tsoi B.

J Am Soc Hypertens. 2016 Jan;10(1):55-69.e1. doi: 10.1016/j.jash.2015.11.005. Epub 2015 Dec 1.

PMID:
26684588
6.

The effect of angiotensin II receptor blockers on hyperuricemia.

Wolff ML, Cruz JL, Vanderman AJ, Brown JN.

Ther Adv Chronic Dis. 2015 Nov;6(6):339-46. doi: 10.1177/2040622315596119. Review.

8.

Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population: a meta-analysis.

Fan Y, Wei F, Lang Y, Wang S.

J Hypertens. 2015 Apr;33(4):681-8; discussion 689. doi: 10.1097/HJH.0000000000000478.

PMID:
25915869
9.

Efficacy and safety of eplerenone in the management of mild to moderate arterial hypertension: systematic review and meta-analysis.

Pelliccia F, Patti G, Rosano G, Greco C, Gaudio C.

Int J Cardiol. 2014 Nov 15;177(1):219-28. doi: 10.1016/j.ijcard.2014.09.091. Epub 2014 Oct 14. Review.

PMID:
25499383
10.

Evaluation of blood pressure reduction response and responder characteristics to fixed-dose combination treatment of amlodipine and losartan: a post hoc analysis of pooled clinical trials.

Unniachan S, Wu D, Rajagopalan S, Hanson ME, Fujita KP.

J Clin Hypertens (Greenwich). 2014 Sep;16(9):671-7. doi: 10.1111/jch.12390. Epub 2014 Aug 7.

11.

Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.

Wang JG, Yan P, Jeffers BW.

J Am Soc Hypertens. 2014 May;8(5):340-9. doi: 10.1016/j.jash.2014.02.004. Epub 2014 Feb 15. Review.

PMID:
24685006
12.

Indirect treatment comparison between fixed-dose-combinations of amlodipine/losartan and amlodipine/valsartan in blood pressure control.

Lawrence Gould A, Unniachan S, Wu D.

Int J Clin Pract. 2014 Feb;68(2):163-72. doi: 10.1111/ijcp.12343. Review.

PMID:
24460615
13.

Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis.

Makani H, Bangalore S, Supariwala A, Romero J, Argulian E, Messerli FH.

Eur Heart J. 2014 Jul;35(26):1732-42. doi: 10.1093/eurheartj/eht333. Epub 2013 Aug 21. Review.

PMID:
23966312
14.

A meta-analysis of randomized trials of telmisartan versus losartan for reduction of ambulatory blood pressure.

Takagi H, Niwa M, Mizuno Y, Goto SN, Umemoto T; All-Literature Investigation of Cardiovascular Evidence Group..

Hypertens Res. 2013 Nov;36(11):959-66. doi: 10.1038/hr.2013.78. Epub 2013 Aug 15.

PMID:
23945962
15.

Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.

He YM, Feng L, Huo DM, Yang ZH, Liao YH.

Nephrology (Carlton). 2013 Sep;18(9):605-14. doi: 10.1111/nep.12134. Review.

PMID:
23869492
16.

A review of the use of angiotensin receptor blockers for the prevention of cardiovascular events in patients with essential hypertension without compelling indications.

Zaiken K, Hudd TR, Cheng JW.

Ann Pharmacother. 2013 May;47(5):686-93. doi: 10.1345/aph.1R273. Epub 2013 Apr 12. Review.

PMID:
23585649
17.

Mechanisms of cyclosporine-induced renal cell apoptosis: a systematic review.

Xiao Z, Shan J, Li C, Luo L, Lu J, Li S, Long D, Li Y.

Am J Nephrol. 2013;37(1):30-40. doi: 10.1159/000345988. Epub 2012 Dec 28. Review.

18.

Pharmaco-nutrient interactions - a systematic review of zinc and antihypertensive therapy.

Braun LA, Rosenfeldt F.

Int J Clin Pract. 2013 Aug;67(8):717-25. doi: 10.1111/ijcp.12040. Epub 2012 Dec 26. Review.

PMID:
23279674
19.

Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.

Inglis SC, Bebchuk J, Al-Suhaim SA, Case J, Pfeffer MA, Solomon SD, Hou YR, Pitt B, Dargie HJ, Ford I, Kjekshus J, Zannad F, Dickstein K, McMurray JJ.

Int J Cardiol. 2013 Sep 30;168(2):1094-101. doi: 10.1016/j.ijcard.2012.11.033. Epub 2012 Nov 26.

PMID:
23194780
20.

Antihypertensive effects of olmesartan compared with other angiotensin receptor blockers: a meta-analysis.

Wang L, Zhao JW, Liu B, Shi D, Zou Z, Shi XY.

Am J Cardiovasc Drugs. 2012 Oct 1;12(5):335-44. doi: 10.2165/11597390-000000000-00000. Review.

PMID:
22920046

Supplemental Content

Loading ...
Support Center